Cargando…
Characterization of the Diagnostic Performance of a Novel COVID-19 PETIA in Comparison to Four Routine N-, S- and RBD-Antigen Based Immunoassays
In 2019, a novel coronavirus emerged in Wuhan in the province of Hubei, China. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) quickly spread across the globe, causing the neoteric COVID-19 pandemic. SARS-CoV-2 is commonly transmitted by droplet infection and aerosols when coughing...
Autores principales: | Spaeth, Alexander, Masetto, Thomas, Brehm, Jessica, Wey, Leoni, Kochem, Christian, Brehm, Martin, Peter, Christoph, Grimmler, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394885/ https://www.ncbi.nlm.nih.gov/pubmed/34441268 http://dx.doi.org/10.3390/diagnostics11081332 |
Ejemplares similares
-
Bioinformatical Design and Performance Evaluation of a Nucleocapsid- and an RBD-Based Particle Enhanced Turbidimetric Immunoassay (PETIA) to Quantify the Wild Type and Variants of Concern-Derived Immunoreactivity of SARS-CoV-2
por: Wey, Leoni, et al.
Publicado: (2023) -
SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients – a comparative long term post-infection study
por: Brehm, Jessica, et al.
Publicado: (2022) -
Analytical validation of Gentian NGAL particle-enhanced enhanced turbidimetric immunoassay (PETIA)
por: Salvagno, Gian Luca, et al.
Publicado: (2017) -
Comparison of four routinely used vitamin D automated immunoassays
por: Windrichova, Jindra, et al.
Publicado: (2021) -
Letter to the Editor regarding “Development of an antibody-free ID-LC MS method for the quantification of procalcitonin in human serum at sub-microgram per liter level using a peptide-based calibration”
por: Tölke, Sebastian-Alexander, et al.
Publicado: (2021)